trending Market Intelligence /marketintelligence/en/news-insights/trending/diz7qzjc1kjb8jlvgih9ag2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Meridian's blood-diagnostic system to be introduced in China

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Meridian's blood-diagnostic system to be introduced in China

MedCaptain Medical Technology Co. Ltd. secured a license to introduce Meridian Bioscience Inc.'s blood-diagnostic system in China.

The LeadCare II system, which will begin distributing in January 2017, is meant to diagnose lead exposure in the bloodstream.

MedCaptain will educate Chinese physicians and consumers about the risks and management of lead poisoning. Meridian estimates that between 9% and 25% of the Chinese population is exposed to lead as a result of the battery manufacturing/recycling, e-waste, mining and smelting industries.